Global Efavirenz Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Efavirenz Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Single Efavirenz
  • 1.2.2 Two-drug combination
  • 1.2.3 Three-drug combination
• 1.3 Market Analysis by Applications
  • 1.3.1 Adults
  • 1.3.2 Children
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2013-2023)
    • 1.4.1.2 Canada Market States and Outlook (2013-2023)
    • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2013-2023)
    • 1.4.2.2 France Market States and Outlook (2013-2023)
    • 1.4.2.3 UK Market States and Outlook (2013-2023)
    • 1.4.2.4 Russia Market States and Outlook (2013-2023)
    • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2013-2023)
    • 1.4.3.2 Japan Market States and Outlook (2013-2023)
    • 1.4.3.3 Korea Market States and Outlook (2013-2023)
    • 1.4.3.4 India Market States and Outlook (2013-2023)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
    • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
    • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Bristol-Myers Squibb
  • 2.1.1 Business Overview
  • 2.1.2 Efavirenz Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Bristol-Myers Squibb Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.2 Teva
  • 2.2.1 Business Overview
  • 2.2.2 Efavirenz Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Teva Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.3 Mylan
  • 2.3.1 Business Overview
  • 2.3.2 Efavirenz Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Mylan Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.4 Aurobindo Pharma
  • 2.4.1 Business Overview
  • 2.4.2 Efavirenz Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Aurobindo Pharma Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.5 Cipla
  • 2.5.1 Business Overview
  • 2.5.2 Efavirenz Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Cipla Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.6 Macleods Pharmaceuticals
  • 2.6.1 Business Overview
  • 2.6.2 Efavirenz Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Macleods Pharmaceuticals Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.7 Hetero
  • 2.7.1 Business Overview
  • 2.7.2 Efavirenz Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Hetero Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.8 Strides Pharma
  • 2.8.1 Business Overview
  • 2.8.2 Efavirenz Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Strides Pharma Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.9 Gilead Sciences
  • 2.9.1 Business Overview
  • 2.9.2 Efavirenz Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Gilead Sciences Efavirenz Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Efavirenz Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

• 3.1 Global Efavirenz Sales and Market Share by Manufacturer (2016-2017)
• 3.2 Global Efavirenz Revenue and Market Share by Manufacturer (2016-2017)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Efavirenz Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Efavirenz Manufacturer Market Share in 2017
• 3.4 Market Competition Trend

4 Global Efavirenz Market Analysis by Regions

• 4.1 Global Efavirenz Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Efavirenz Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Efavirenz Revenue and Market Share by Regions (2013-2018)
• 4.2 North America Efavirenz Sales and Growth Rate (2013-2018)
• 4.3 Europe Efavirenz Sales and Growth Rate (2013-2018)
• 4.4 Asia-Pacific Efavirenz Sales and Growth Rate (2013-2018)
• 4.5 South America Efavirenz Sales and Growth Rate (2013-2018)
• 4.6 Middle East and Africa Efavirenz Sales and Growth Rate (2013-2018)

5 North America Efavirenz by Countries

• 5.1 North America Efavirenz Sales, Revenue and Market Share by Countries
  • 5.1.1 North America Efavirenz Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Efavirenz Revenue and Market Share by Countries (2013-2018)
• 5.2 United States Efavirenz Sales and Growth Rate (2013-2018)
• 5.3 Canada Efavirenz Sales and Growth Rate (2013-2018)
• 5.4 Mexico Efavirenz Sales and Growth Rate (2013-2018)

6 Europe Efavirenz by Countries

• 6.1 Europe Efavirenz Sales, Revenue and Market Share by Countries
  • 6.1.1 Europe Efavirenz Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Efavirenz Revenue and Market Share by Countries (2013-2018)
• 6.2 Germany Efavirenz Sales and Growth Rate (2013-2018)
• 6.3 UK Efavirenz Sales and Growth Rate (2013-2018)
• 6.4 France Efavirenz Sales and Growth Rate (2013-2018)
• 6.5 Russia Efavirenz Sales and Growth Rate (2013-2018)
• 6.6 Italy Efavirenz Sales and Growth Rate (2013-2018)

7 Asia-Pacific Efavirenz by Countries

• 7.1 Asia-Pacific Efavirenz Sales, Revenue and Market Share by Countries
  • 7.1.1 Asia-Pacific Efavirenz Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Efavirenz Revenue and Market Share by Countries (2013-2018)
• 7.2 China Efavirenz Sales and Growth Rate (2013-2018)
• 7.3 Japan Efavirenz Sales and Growth Rate (2013-2018)
• 7.4 Korea Efavirenz Sales and Growth Rate (2013-2018)
• 7.5 India Efavirenz Sales and Growth Rate (2013-2018)
• 7.6 Southeast Asia Efavirenz Sales and Growth Rate (2013-2018)

8 South America Efavirenz by Countries

• 8.1 South America Efavirenz Sales, Revenue and Market Share by Countries
  • 8.1.1 South America Efavirenz Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Efavirenz Revenue and Market Share by Countries (2013-2018)
• 8.2 Brazil Efavirenz Sales and Growth Rate (2013-2018)
• 8.3 Argentina Efavirenz Sales and Growth Rate (2013-2018)
• 8.4 Colombia Efavirenz Sales and Growth Rate (2013-2018)

9 Middle East and Africa Efavirenz by Countries

• 9.1 Middle East and Africa Efavirenz Sales, Revenue and Market Share by Countries
  • 9.1.1 Middle East and Africa Efavirenz Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Efavirenz Revenue and Market Share by Countries (2013-2018)
• 9.2 Saudi Arabia Efavirenz Sales and Growth Rate (2013-2018)
• 9.3 UAE Efavirenz Sales and Growth Rate (2013-2018)
• 9.4 Egypt Efavirenz Sales and Growth Rate (2013-2018)
• 9.5 Nigeria Efavirenz Sales and Growth Rate (2013-2018)
• 9.6 South Africa Efavirenz Sales and Growth Rate (2013-2018)

10 Global Efavirenz Market Segment by Type

• 10.1 Global Efavirenz Sales, Revenue and Market Share by Type (2013-2018)
  • 10.1.1 Global Efavirenz Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Efavirenz Revenue and Market Share by Type (2013-2018)
• 10.2 Single Efavirenz Sales Growth and Price
  • 10.2.1 Global Single Efavirenz Sales Growth (2013-2018)
  • 10.2.2 Global Single Efavirenz Price (2013-2018)
• 10.3 Two-drug combination Sales Growth and Price
  • 10.3.1 Global Two-drug combination Sales Growth (2013-2018)
  • 10.3.2 Global Two-drug combination Price (2013-2018)
• 10.4 Three-drug combination Sales Growth and Price
  • 10.4.1 Global Three-drug combination Sales Growth (2013-2018)
  • 10.4.2 Global Three-drug combination Price (2013-2018)

11 Global Efavirenz Market Segment by Application

• 11.1 Global Efavirenz Sales Market Share by Application (2013-2018)
• 11.2 Adults Sales Growth (2013-2018)
• 11.3 Children Sales Growth (2013-2018)

12 Efavirenz Market Forecast (2018-2023)

• 12.1 Global Efavirenz Sales, Revenue and Growth Rate (2018-2023)
• 12.2 Efavirenz Market Forecast by Regions (2018-2023)
  • 12.2.1 North America Efavirenz Market Forecast (2018-2023)
  • 12.2.2 Europe Efavirenz Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Efavirenz Market Forecast (2018-2023)
  • 12.2.4 South America Efavirenz Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Efavirenz Market Forecast (2018-2023)
• 12.3 Efavirenz Market Forecast by Type (2018-2023)
  • 12.3.1 Global Efavirenz Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Efavirenz Market Share Forecast by Type (2018-2023)
• 12.4 Efavirenz Market Forecast by Application (2018-2023)
  • 12.4.1 Global Efavirenz Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Efavirenz Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology